Wanbury Launches Pediatric Coriminic CPM, NS Drops

Wanbury Limited launched Coriminic CPM Drops (Chlorpheniramine Maleate) and Coriminic NS Nasal Drops for children under 4 years.
The launches address DCGI restrictions on fixed-dose combinations (Chlorpheniramine + Phenylephrine) in children below 4 years due to safety concerns.
The strategic move targets the ₹861 crore Cold Preparation Liquid market, strengthening Wanbury's pediatric portfolio.